$133.97
At close: Apr 8 EDT
$133.97
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
ICU Medical Stock Guidance | NASDAQ:ICUI | Benzinga
ICU Medical issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | ICUI | ICU Medical | FY | 2025 | $6.55 | $7.25 | $7.13 | — | — | — | Get Alert |
| 11/12/2024 | ICUI | ICU Medical | FY | 2024 | $5.40 | $5.70 | $5.22 | — | — | — | Get Alert |
| 08/07/2024 | ICUI | ICU Medical | FY | 2024 | $4.95 | $5.35 | $4.83 | — | — | — | Get Alert |
| 05/07/2024 | ICUI | ICU Medical | FY | 2024 | $4.40 | $5.10 | $4.73 | — | — | — | Get Alert |
| 02/27/2024 | ICUI | ICU Medical | FY | 2024 | $4.40 | $5.10 | $5.18 | — | — | — | Get Alert |
| 11/06/2023 | ICUI | ICU Medical | FY | 2023 | $6.43 | $6.43 | $6.59 | — | — | — | Get Alert |
| 08/07/2023 | ICUI | ICU Medical | FY | 2023 | $6.00 | $6.85 | $7.08 | — | — | — | Get Alert |
| 02/27/2023 | ICUI | ICU Medical | FY | 2023 | $5.75 | $7.25 | $7.22 | — | — | — | Get Alert |
| 11/07/2022 | ICUI | ICU Medical | FY | 2022 | $6.20 | $6.80 | $6.52 | — | — | — | Get Alert |
| 08/08/2022 | ICUI | ICU Medical | FY | 2022 | $6.20 | $6.80 | $9.17 | — | — | — | Get Alert |
| 02/24/2022 | ICUI | ICU Medical | FY | 2022 | $9.00 | $10.50 | $7.76 | — | — | — | Get Alert |
| 08/04/2021 | ICUI | ICU Medical | FY | 2021 | $6.80 | $7.20 | $6.93 | — | — | — | Get Alert |
| 02/25/2021 | ICUI | ICU Medical | FY | 2021 | $6.50 | $7.20 | $7.16 | — | — | — | Get Alert |
| 11/05/2020 | ICUI | ICU Medical | FY | 2020 | $6.65 | $7.00 | $6.40 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for ICU Medical (ICUI)?
The most recent guidance for ICU Medical (ICUI) was reported on February 27, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $6.55 to $7.25, compared to the estimated EPS of $7.13. Additionally, ICU Medical forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.